Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Sell
20,460
-628
-3% -$56.9K 0.01% 1020
2026
Q1
$1.69M Buy
21,088
+1,377
+7% +$116K 0.01% 994
2025
Q4
$1.46M Buy
19,711
+1,455
+8% +$103K 0.01% 1023
2025
Q3
$1.14M Sell
18,256
-288
-2% -$17.7K 0.01% 1022
2025
Q2
$1.05M Buy
18,544
+5,962
+47% +$315K 0.01% 956
2025
Q1
$712K Buy
12,582
+3,629
+41% +$227K 0.01% 970
2024
Q4
$566K Buy
8,953
+413
+5% +$25.5K 0.01% 1029
2024
Q3
$531K Buy
+8,540
New +$537K 0.01% 842

Other funds holding HXL

&Partners's HXL Position: Q2 2026 in Review

&Partners reduced its Hexcel (HXL) stake by 3% in Q2 2026, selling an estimated $56.9K and leaving 20,460 shares worth $2.04M. The position accounts for 0.01% of the portfolio, ranked #1020.

&Partners first reported a position in HXL in Q3 2024 and has held it in 8 quarters since. 530 funds tracked by Wall St. Rank hold HXL as of Q2 2026.

  • &Partners held 20,460 shares of Hexcel worth $2.04M as of Q2 2026.
  • &Partners sold 628 Hexcel shares in Q2 2026, an estimated $56.9K.
  • Hexcel made up 0.01% of &Partners's portfolio in Q2 2026, its #1020 holding.
  • &Partners first reported a position in Hexcel in Q3 2024 and has held it in 8 quarters since.
  • 530 funds tracked by Wall St. Rank held Hexcel as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.